Last updated on August 2019
FIRAZYR General Drug Use-Results Survey (Japan)
Brief description of study
The objectives of this survey are to collect data to report the safety and efficacy of Firazyr (Icatibant acetate) in the post-marketing phase in participants diagnosed with Hereditary Angioedema (HAE).
Clinical Study Identifier: NCT04057131
